Cargando…
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
The abilities of chemokines in orchestrating cellular migration are utilised by different (patho-)biological networks including malignancies. However, except for CXCR4/CXCL12, little is known about the relation between tumour-related chemokine expression and the development and progression of solid...
Autores principales: | Panse, J, Friedrichs, K, Marx, A, Hildebrandt, Y, Luetkens, T, Bartels, K, Horn, C, Stahl, T, Cao, Y, Milde-Langosch, K, Niendorf, A, Kröger, N, Wenzel, S, Leuwer, R, Bokemeyer, C, Hegewisch-Becker, S, Atanackovic, D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538749/ https://www.ncbi.nlm.nih.gov/pubmed/18781150 http://dx.doi.org/10.1038/sj.bjc.6604621 |
Ejemplares similares
-
Ectopic expression of the chemokine CXCL17 in colon cancer cells
por: Ohlsson, Lina, et al.
Publicado: (2016) -
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
por: Popple, A, et al.
Publicado: (2012) -
C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma
por: Mahner, S, et al.
Publicado: (2008) -
Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016) -
Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer
por: Milde-Langosch, K, et al.
Publicado: (2005)